The goal of this live webinar is to introduce researchers and starting biopharma companies to the techniques used in the characterization of biopharmaceuticals. We will cover the most important critical quality attributes and ways to analyze them. We will also compare LC and LC-MS techniques and comment on the pros and cons of each approach. …

Continue reading “Characterization of biopharmaceuticals by (U)HPLC and LC-MS”

Testa Center in 100 words

We offer businesses and academia globally a modern, pilot-scale testbed for projects and education in production of biological products e.g. monoclonal antibodies, peptides, protein, vaccine and viral vectors (non-GMP, up to Bio-safety level 2 and 500 liter).

In our flexible facility, and with some helping hands of our experienced staff, you can perform a wide variety of projects, including scale-up of parts of a process, or a complete process from frozen cell bank vial to purified protein.

Testa Center is a major initiative between the Swedish government and Cytiva (formerly GE Life Sciences) to secure the growth of life science industry and its manufacturing capabilities. Main objective for Testa Center is to bridge the gap from discovery to industrialization.

Testa Center is operated as a non-profit company, owned by Cytiva.